Results 281 to 290 of about 1,136,512 (313)
Some of the next articles are maybe not open access.

Cardiovascular medicine: a year in review

Minerva Cardiology and Angiology, 2022
Cardiovascular medicine is facing several challenges in the current era, dominated by the rapid spread of a previously unknown virus around the world. Indeed, the 2020 COVID-19 pandemic set the course of cardiovascular science and education in an extraordinary way, hogging the attention of the medical community.
Matteucci, Andrea   +7 more
openaire   +5 more sources

Colchicine for Cardiovascular Medicine

Future Cardiology, 2015
Colchicine is an ancient drug with anti-inflammatory effects especially on neutrophils. These cells are critically involved in pericardial and atherosclerotic plaques inflammation, thus representing a new potential target for new therapies to treat and especially prevent cardiovascular events such as pericarditis, atrial fibrillation triggered by ...
Massimo Imazio, Fiorenzo Gaita
openaire   +3 more sources

Biomarkers in Cardiovascular Medicine

Revista Española de Cardiología (English Edition), 2009
Cardiovascular disease is the principal cause of death in developed countries. The underlying pathological process is arterial wall thickening due to the formation of atherosclerotic plaque, which is frequently complicated by thrombus, thereby giving rise to the possibility of acute coronary syndrome or stroke.
Begoña Muñoz-García   +7 more
openaire   +3 more sources

Cardiovascular nuclear medicine

Seminars in Nuclear Medicine, 1977
Exciting developments in radiopharmaceuticals and instrumentation have established the field of cardiovascular nuclear medicine as an extremely useful clinical tool. Depending on the patient's problem, one may elect to perform myocardial perfusion images with 201Tl, infarct avid images with 99m Tc, or wall motion and other functional studies with ...
B, Pitt, H W, Strauss
openaire   +2 more sources

Photonics in cardiovascular medicine

Nature Photonics, 2015
The use of photonics technology is bringing new capabilities and insights to cardiovascular medicine. Intracoronary imaging and sensing, laser ablation and optical pacing are just some of the functions being explored to help diagnose and treat conditions of the heart and arteries.
Evelyn Regar   +2 more
openaire   +2 more sources

Herbal medicine and cardiovascular diseases

Therapeutische Umschau, 2002
Phytotherapeutika werden häufig von Patienten mit kardiovaskulären Problemen eingenommen. Ihr Nutzen ist umstritten, da die Datenlage der meisten Substanzen ungenügend ist. Für die drei Substanzen Ginkgo biloba, Crataegus und Knoblauch existieren aber eine Vielzahl von experimentellen und klinischen Studien, welche teilweise den Kriterien der Evidence-
Zbinden S, Seiler Ch
openaire   +3 more sources

Cardiovascular Medicine

2019
The field of cardiovascular medicine is an inexhaustible source for clinical trials (→ OHCM 10th edition:). The most feasible way of keeping up to date is referring to guidelines. In addition to those made avail­able by the National Institute for Health and Care Excellence (NICE), the European Society of Cardiology (ESC) provides very useful Clinical ...
openaire   +1 more source

Pharmacoeconomics of Cardiovascular Medicine

2001
The growth of managed care in the 1980s and 1990s and the resulting emphasis on cost containment have impacted the practice of cardiovascular medicine as we enter the twenty-first century. In this age of limited economic resources, it is no longer appropriate to embrace all advancements, however minor, in health care technology.
R Corey   +2 more
openaire   +2 more sources

Pharmacogenetics in Cardiovascular Medicine

2018
Considerable interindividual variability in response to cardiovascular pharmacotherapy exists with drug responses varying from being efficacious to inadequate to induce severe adverse events. Fueled by advancements and multidisciplinary collaboration across disciplines such as genetics, bioinformatics, and basic research, the vision of personalized ...
openaire   +3 more sources

The challenge of polypharmacy in cardiovascular medicine

Fundamental & Clinical Pharmacology, 2010
AbstractAlbeit great efforts in reducing the burden of cardiovascular diseases (CVD), their prevalence continues to grow worldwide. Among the causes for this rising burden, the upcoming pandemic of obesity and diabetes further enhances the estimates of CV mortality and healthcare costs over the next decades.
VOLPE, Massimo   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy